Social Media Ideas for Buck Institute

<![CDATA[BioMarin and n-Lorem Foundation Enter Research Collaboration for ReNU Syndrome Treatment ]]>

<![CDATA[Pharmaceutical Executive Daily: BioMarin and n-Lorem Foundation Enter Collaboration]]>

Sunshine Guojian Releases 2026 Interim Report:

Innovation-driven, Steady Advancement

Goda Lab Advances to Final XPRIZE Healthspan Phase with Breakthrough Super Exosomes

A research team in Japan has won a US$1 million Milestone 2 award in the XPRIZE Healthspan competition for developing engineered “super exosomes,” microscopic biological delivery v...

Watchmaker Genomics Boosts Manufacturing Capacity with Major Boulder Campus Expansion

The Flatiron Park facility in Colorado will serve as the Watchmaker Boulder Manufacturing Center of Excellence for reagent manufacturing and will house the company’s manufacturing,...

Thermo and Michael J. Fox Foundation Collaborate to Advance Proteomics-Enabled Parkinson’s Therapy

PPMI creates a large-scale proteomics resource designed to help researchers study Parkinson’s disease at the protein level and investigate biological signals associated with diseas...

DualityBio Enters a Global Collaboration and License Agreement with Genentech to Develop Next-Generation ADCs Built on D...

Collaboration leverages DualityBio's proprietary DUPAC payload platform and early global clinical development capabilities, with Genentech assuming further clinical development and...

Mount Sinai Reaches Milestone 2 in $101 Million XPRIZE Healthspan Competition

New York, NY — August 11, 2026 — Researchers at the Icahn School of Medicine at Mount Sinai have advanced to the finals of XPRIZE Healthspan, a $101 million global competition seek...

UCSD, IGI Partnership Expands CRISPR Innovation Across Health, Agriculture, and the Environment

UC San Diego has joined the Innovative Genomics Institute as its fourth UC partner, expanding collaboration to develop next-generation genome-editing technologies that address majo...

Lupin Spins Out Two Oncology Programs to Kaveri Therapeutics to Advance its Oncology Strategy

Aims to Raise Capital to Fund Global Clinical Studies for LNP7457 (PRMT5) & LNP8701 (SOS1)

Startup Boulevard Bio Launches With Immune Reset Pioneer Schett as Co-Founder

Deerfield Management formed Boulevard Bio with scientific co-founders Georg Schett and Frank Nestle. The startup’s lead program is in early clinical development for an autoimmune k...

Boulevard starts up with $65M to pursue targeted autoimmune drugs

Co-founded by pioneering researcher Georg Schett and ex-Sanofi CSO Frank Nestle, the startup is advancing a trio of multifaceted antibodies with the potential to treat several immu...

Deerfield-backed Boulevard Bio embarks on ‘beautiful path to a cure’ with trio of immunology drugs

Boulevard Bio has strolled out of stealth with $65 million in funding from Deerfield Management and three autoimmune disease candidates.

<![CDATA[Insilico Medicine Enters $2.5 Billion Alliance with Bora Pharmaceuticals ]]>

Bicistornic Vectors + piggyBac = Improved Antibody Cell Line Production

To produce stable cell lines for monoclonal antibody production, manufacturers typically use the piggyBac transposon system. For larger, multi-specific antibodies that have payload...

Fred Hutch Announces 2026 Evergreen Fund Awardees

Seattle-based Fred Hutch Cancer Center has announced $975,000 in internal Evergreen Fund support for eight research teams, aiming to translate promising laboratory findings into ne...

UCSF QBI Awarded $46M to Translate Landmark Autism Map Into Precision Therapies

A landmark molecular map revealed shared pathways connecting diverse autism risk genes. Now, a $46 million investment will help QBI scientists and their collaborators pursue new pr...

Bioz and InvivoGen Elevate Scientific Discovery with an Expanded Digital Research Experience

Infleqtion Names Dr. Joseph Buck Senior Vice President of Quantum Computing Systems

Insider Brief Press release – Infleqtion (NYSE: INFQ), a quantum computing and quantum sensing company powered by neutral-atom technology, today announced the appointment of Dr. Jo...